Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eric J Ende Insider Profile
11 Followers
Eric J Ende, Director at Matinas BioPharma, holds 178.90K shares in Avadel Pharmaceuticals (Ticker: AVDL), holds 144.09K shares in Matinas BioPharma (Ticker: MTNB), holds ― shares in Progenics (Ticker: PGNX).
Profitable Transactions
6 out of 6 Profitable Transactions
Average Return
+185.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Eric J Ende holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 31, 2022 - May 31, 2023
Return:+526.60%
The most profitable trade made by Eric J Ende
Eric J Ende's Trading History
Matinas BioPharma
Jun 24, 2021
Director
Uninformative Buy
―
$78.53K
Avadel Pharmaceuticals
Aug 01, 2024
Director
Uninformative Buy
―
$1.84M
Progenics
―
―
―
―
NeuBase Therapeutics
―
―
―
―
List of latest transactions for each holding click on a transaction to see Eric J Ende's performance on stock
You May Also Like
Eric J Ende insider profile FAQ
What is the percentage of profitable transactions made by Eric J Ende?
The percentage of profitable transactions made by Eric J Ende is 100%.
What is the average return per transaction made by Eric J Ende?
The average return per transaction made by Eric J Ende is 185.10%.
What stocks does Eric J Ende hold?
Eric J Ende holds: MTNB, AVDL, PGNX, NBSE stocks.
What was Eric J Ende’s latest transaction?
Eric J Ende latest transaction was an Uninformative Buy of ―.
What was Eric J Ende's most profitable transaction?
Eric J Ende’s most profitable transaction was an Informative Buy of AVDL stock on May 31, 2022. The return on the trade was 526.60%.
What is Eric J Ende's role in Matinas BioPharma?
Eric J Ende's role in Matinas BioPharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.